Results 131 to 140 of about 10,425 (248)
Abstract Background and aims Data on the presence of new psychoactive substances (NPS) mainly originate from drug‐checking, law enforcement and wastewater analysis sources, while data on NPS poisonings are scarce. In Europe, the documented incidence rate of NPS poisonings is highest in the Netherlands.
Johanna J. Nugteren‐van Lonkhuyzen +5 more
wiley +1 more source
Abstract Background and aims Cannabis cue reactivity paradigms are instrumental in studying the behavioral and neurocognitive mechanisms of cannabis use and cannabis use disorders; however, image sets used for cannabis cue reactivity paradigms vary between studies, and the lack of reliability and validity assessment hinders the quality of evidence they
Janna Cousijn +6 more
wiley +1 more source
Evolving health policy and regulatory oversight of medicinal cannabis in Australia: lessons for sustainable integration. [PDF]
Lim ECN, Lim CED.
europepmc +1 more source
Beyond abstinence: Redefining success in cannabis use disorder treatment
Abstract Background Over two decades of pharmacotherapy research has yet to yield a consistently effective medication for cannabis use disorder (CUD), in part because clinical trials have frequently prioritized abstinence as a primary or key endpoint.
Tobias B. Atkin +3 more
wiley +1 more source
Medicinal cannabis: is current use clinically justified? [PDF]
Scott RJ, Scott IA.
europepmc +1 more source
Abstract Background and aims Although many people who use cannabis report mood‐enhancing effects, affective responses are thought to vary within and between individuals. This study examined the bidirectional associations between momentary affect and cannabis use and the potential moderating role of emotion regulation in this.
Ana Paula Gonçalves Donate +3 more
wiley +1 more source
Abstract Background/aims Take‐home naloxone (THN) programmes have been introduced in many European countries to provide non‐medically trained people who are likely to witness an opioid overdose, including people who use opioids, with a naloxone kit and training.
Nicola Metrebian +31 more
wiley +1 more source
Medicinal cannabis for tics in adolescents with Tourette syndrome. [PDF]
Eapen V +11 more
europepmc +1 more source
Abstract Background and aims Brief interventions delivered in healthcare settings represent a promising substance use prevention and early intervention strategy for youth in foster care, among whom early life adversity and resulting psychological sequalae increase risk for problematic substance use.
Courtney B. Dunn +4 more
wiley +1 more source
Weighted prevalence of biochemically verified substance use in healthy adolescents across the USA
Abstract Background and aims Adolescent substance use is a significant public health concern, though the scope of the problem is difficult to ascertain given reliance on self‐reported substance use information. Recent, large cohort studies in adolescents and young adults suggest underreporting of substance use.
Natasha E. Wade +14 more
wiley +1 more source

